Evidence map›Paper›PMID 35268790›Full record

ReviewMolecules (Basel, Switzerland)2022

The Medicinal Natural Products of

Anwuli Endurance Odieka, Gloria Ukalina Obuzor, Opeoluwa Oyehan Oyedeji, Mavuto Gondwe, Yiseyon Sunday Hosu, Adebola Omowunmi Oyedeji

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Article
  3. Frontiers in pharmacology · 2026
    Article
  4. Article
  5. Article
  6. New Cannabinoids and Chlorin-Type Metabolites from the Flowers ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Is There a Place for Cannabinoids in Asthma Treatment?International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Medicinal Cannabis and the Intestinal Microbiome.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anwuli Endurance OdiekaDepartment of Chemical and Physical Sciences, Walter Sisulu University, Mthatha 5099, South Africa.ORCID 0000-0001-5465-7102
Gloria Ukalina ObuzorDepartment of Pure and Industrial Chemistry, University of Port Harcourt, Port Harcourt 500004, Rivers State, Nigeria.
Opeoluwa Oyehan OyedejiDepartment of Chemistry, Fort Hare University, Alice 5700, South Africa.ORCID 0000-0002-1240-3718
Mavuto GondweDepartment of Human Biology, Walter Sisulu University, Mthatha 5099, South Africa.ORCID 0000-0002-1684-801X
Yiseyon Sunday HosuDepartment of Economics and Business Sciences, Walter Sisulu University, Mthatha 5099, South Africa.ORCID 0000-0001-9078-7748
Adebola Omowunmi OyedejiDepartment of Chemical and Physical Sciences, Walter Sisulu University, Mthatha 5099, South Africa.ORCID 0000-0001-8765-7766

Funding

National Research Foundation 130205; 137963
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabinoidsCannabisBiological ProductsHumansPhytochemicalsPlant ExtractsPlants, MedicinalBiological ProductsCannabinoidsPhytochemicalsPlant ExtractsbioactivityCannabis sativacharacterizationextraction methodsmedicinal plantphytochemicals

Identifiers

PMID35268790
PMCPMC8911748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.